Cannara Biotech Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 3, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Market Cap	185	165	61	90	118	149
Market Cap Growth	69.82%	168.86%	-32.22%	-23.72%	-20.54%	36.01%
Enterprise Value	203.01	191.8	102.92	131.82	154.67	161.74
PE Ratio	15.69	12.86	9.71	12.50	45.00	-17.00
Forward PE	13.05	-	-	-	-	-
PS Ratio	1.65	1.53	0.75	1.57	3.29	8.63
PB Ratio	1.66	1.61	0.70	1.13	1.77	2.32
P/TBV Ratio	-	1.63	0.71	1.13	1.78	2.03
P/FCF Ratio	14.92	12.05	19.05	-22.76	-5.49	-4.49
P/OCF Ratio	8.34	8.22	5.73	15.28	-19.48	-71.19
EV/Sales Ratio	1.81	1.79	1.25	2.29	4.30	9.37
EV/EBITDA Ratio	7.56	6.64	6.26	7.83	17.45	49.26
EV/EBIT Ratio	10.09	8.64	10.21	11.09	31.31	628.63
EV/FCF Ratio	16.40	14.05	32.02	-33.22	-7.18	-4.88
Debt / Equity Ratio	-	0.41	0.55	0.57	0.73	0.33
Debt / EBITDA Ratio	-	1.44	2.94	2.72	5.46	6.36
Debt / FCF Ratio	-	3.05	15.04	-11.54	-2.25	-0.63
Net Debt / Equity Ratio	-	0.27	0.47	0.52	0.54	0.20
Net Debt / EBITDA Ratio	-	0.94	2.54	2.47	4.09	3.88
Net Debt / FCF Ratio	-	1.99	12.98	-10.46	-1.68	-0.38
Asset Turnover	1.40	0.66	0.55	0.43	0.33	0.19
Inventory Turnover	2.17	1.32	1.41	1.38	1.66	1.15
Quick Ratio	-	0.83	0.73	0.70	1.75	1.64
Current Ratio	-	2.40	2.50	2.44	3.46	2.82
Return on Equity (ROE)	26.08%	13.75%	7.68%	9.48%	3.52%	-2.38%
Return on Assets (ROA)	32.11%	17.54%	3.84%	8.90%	4.54%	0.28%
Return on Invested Capital (ROIC)	37.23%	20.15%	4.26%	10.22%	5.44%	0.33%
Return on Capital Employed (ROCE)	33.20%	16.93%	8.13%	10.16%	4.97%	0.30%
Earnings Yield	6.39%	7.78%	10.29%	8.00%	2.22%	-5.88%
FCF Yield	6.70%	8.30%	5.25%	-4.39%	-18.20%	-22.26%
Buyback Yield / Dilution	-	0.00%	0.45%	0.36%	-0.04%	-16.55%

Updated Nov 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.